Recent KALA News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 08:03:09 PM
- Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities • GlobeNewswire Inc. • 04/01/2026 10:45:00 AM
- KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live • GlobeNewswire Inc. • 03/30/2026 12:45:00 PM
- Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate • GlobeNewswire Inc. • 03/18/2026 01:00:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/17/2026 08:59:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 08:04:20 PM
- KALA BIO plans to release first commercial AI agent within two weeks • IH Market News • 03/11/2026 03:22:00 PM
- Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents • Newsfile • 03/11/2026 03:18:00 PM
- Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates • GlobeNewswire Inc. • 03/11/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 02:16:52 PM
- KALA BIO Announces Strategic Initiative to Deploy and Continue to Develop an On-Premises AI Infrastructure Platform for the Biotech Industry; Enters Into Platform Development and Exclusive License Agreement for Proprietary AI Research Platform “Researgen • GlobeNewswire Inc. • 03/04/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:05:55 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/17/2026 09:44:14 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 09:16:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 09:16:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:05:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 11:01:30 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/26/2026 09:05:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 09:05:28 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/13/2026 01:00:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 09:07:25 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/08/2026 09:05:14 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/06/2026 09:05:13 PM
